Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker.
Bristol Myers Squibb Company wagered $50m in upfront cash on 28 October on insitro’s in vitro modeling technology...








